Efficacy and safety of semaglutide for weight management: evidence from the STEP program-Reference-Cited by-同舟云学术

Efficacy and safety of semaglutide for weight management: evidence from the STEP program

Published:2022-04-14 Issue:sup1 Volume:134 Page:5-17
ISSN:0032-5481
Container-title:Postgraduate Medicine
language:en
Short-container-title:Postgraduate Medicine

Author:

Amaro Anastassia¹^ORCID,Sugimoto Danny²^ORCID,Wharton Sean³^ORCID

Affiliation:

1. Penn Metabolic Medicine, Division of Endocrinology, University of Pennsylvania, Philadelphia, PA, USA

2. Cedar Crosse Research Center, Chicago, IL, USA

3. York University, McMaster University and Wharton Weight Management Clinic, Toronto, Ontario, Canada

Funder

by Novo Nordisk Inc

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00325481.2022.2147326

Reference77 articles.

1. Regarding Obesity as a Disease

2. Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5

3. World Health Organization. Obesity and overweight. 2021 [cited 2022 Jul 21]. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight

4. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Semaglutide in Individuals With Obesity or Overweight Without Diabetes;Cureus;2024-08-27

2. Anti-inflammatory effect of semaglutide: updated systematic review and meta-analysis;Frontiers in Cardiovascular Medicine;2024-07-05

3. Glucagon-Like Peptide 1 Receptor Agonists for Obesity: Efficacy, Side Effects, and Risks;Current Treatment Options in Gastroenterology;2024-07-03

4. Changes in body weight and composition, metabolic parameters, and quality of life in patients with type 2 diabetes treated with subcutaneous semaglutide in real-world clinical practice;Frontiers in Endocrinology;2024-07-02

5. Semaglutide for weight loss: unanswered questions;Frontiers in Endocrinology;2024-06-05